ADGRE2 and systemic inflammatory response syndrome: Clinical data indicate that EMR2 increases in circulating neutrophils in patients with non-infectious systemic inflammatory response syndrome (SIRS) compared to healthy controls [14,19], but neutrophilic EMR2 had been quantified only once in these patients.